AU2001233102A1 - Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody - Google Patents

Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody

Info

Publication number
AU2001233102A1
AU2001233102A1 AU2001233102A AU3310201A AU2001233102A1 AU 2001233102 A1 AU2001233102 A1 AU 2001233102A1 AU 2001233102 A AU2001233102 A AU 2001233102A AU 3310201 A AU3310201 A AU 3310201A AU 2001233102 A1 AU2001233102 A1 AU 2001233102A1
Authority
AU
Australia
Prior art keywords
monoclonal antibody
chimeric anti
recombinant chimeric
ige monoclonal
therapeutic recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233102A
Inventor
Ashok P. Aiyappa
Hongliang Guo
Eugene R. Krah Iii
Robert L. Lawton
Wendy W. Liu
Brion Mermer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of AU2001233102A1 publication Critical patent/AU2001233102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2001233102A 2000-02-01 2001-01-30 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody Abandoned AU2001233102A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17962900P 2000-02-01 2000-02-01
US60179629 2000-02-01
US09/592,998 US6504013B1 (en) 2000-02-01 2000-06-12 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
US09592998 2000-06-12
PCT/US2001/002924 WO2001057090A1 (en) 2000-02-01 2001-01-30 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody

Publications (1)

Publication Number Publication Date
AU2001233102A1 true AU2001233102A1 (en) 2001-08-14

Family

ID=26875491

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233102A Abandoned AU2001233102A1 (en) 2000-02-01 2001-01-30 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody

Country Status (6)

Country Link
US (1) US6504013B1 (en)
EP (1) EP1254180B1 (en)
JP (1) JP4605973B2 (en)
AU (1) AU2001233102A1 (en)
DE (1) DE60127237T2 (en)
WO (1) WO2001057090A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
CA2429372A1 (en) * 2001-01-03 2002-08-29 Heska Corporation Detection of allergen-specific ige
US7261890B2 (en) * 2001-12-21 2007-08-28 Idexx Laboratories, Inc. Methods for using canine immunoglobulin variable domains and caninized antibodies
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
ES2655912T3 (en) * 2002-11-08 2018-02-22 Ablynx N.V. Single domain antibodies directed against tumor necrosis factor-alpha and uses for them
US20100003253A1 (en) * 2002-11-08 2010-01-07 Ablynx N.V. Single domain antibodies directed against epidermal growth factor receptor and uses therefor
WO2004041865A2 (en) * 2002-11-08 2004-05-21 Ablynx N.V. Stabilized single domain antibodies
US20060034845A1 (en) * 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1733232A1 (en) * 2004-03-23 2006-12-20 Quidel Corporation Hybrid phase lateral flow assay
US20090111702A1 (en) * 2004-04-06 2009-04-30 Mount Sinai School Of Medicine Office Of Industrial Liason Methods of determining allergen response using microarray immunoassay techniques
JP2006151880A (en) * 2004-11-30 2006-06-15 Asahi Breweries Ltd MONOCLONAL ANTIBODY AGAINST DOG IgE, METHOD FOR PRODUCING THE SAME, AND USE OF THE SAME
PL1869065T3 (en) 2005-03-11 2020-09-21 Wyeth Llc A method of weak partitioning chromatography
JP2007172129A (en) * 2005-12-20 2007-07-05 Sony Corp Nonvolatile memory access control device and nonvolatile memory control system
RU2491937C2 (en) * 2007-07-09 2013-09-10 Нестек С.А. Method for relieving allergic reactions caused by ambient allergens
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
RS63063B1 (en) 2010-08-19 2022-04-29 Zoetis Belgium S A Anti-ngf antibodies and their use
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6199054B2 (en) * 2013-03-19 2017-09-20 公益財団法人かずさＤｎａ研究所 Anti-canine IgE monoclonal antibody and heavy chain variable region and light chain variable region of anti-canine IgE monoclonal antibody
JP7127859B2 (en) * 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ Treatment of allergic diseases using chimeric proteins
CN109143137B (en) * 2018-06-14 2020-09-29 国电南瑞科技股份有限公司 Method for improving measurement precision of power generator PMU device

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5422258A (en) 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
JP2724625B2 (en) 1987-12-31 1998-03-09 タノックス・バイオシステムズ・インコーポレーテッド Unique antigenic determinants on IgE-producing B lymphocytes
JP2811096B2 (en) * 1989-09-30 1998-10-15 財団法人化学及血清療法研究所 Gene fragment encoding constant region of canine immunoglobulin kappa chain and mouse x dog chimeric antibody
JP2811089B2 (en) * 1989-08-25 1998-10-15 財団法人化学及血清療法研究所 Gene fragments encoding the constant regions of canine x mouse heterohybridomas and canine immunoglobulin lambda chains
JP2837240B2 (en) * 1990-06-07 1998-12-14 財団法人化学及血清療法研究所 Gene fragment encoding constant region of canine immunoglobulin gamma chain and mouse x dog chimeric antibody
CA2113813C (en) * 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
US5965709A (en) 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
SE9102808L (en) 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo VACCIN, HOW TO USE HUMAN USE, WILL BE INTENDED TO EFFECT THE SYMPTOMS OR PREVENT THE RISE OF IGE-MEDIATED ALLERGIC REACTIONS
WO1994020533A1 (en) 1993-03-11 1994-09-15 Tanox Biosystems, Inc. PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE
US5629415A (en) 1994-11-09 1997-05-13 Merck & Co., Inc. DNA encoding canine immunoglobulin E
AU1146897A (en) 1995-12-08 1997-06-27 Idexx Laboratories, Inc. Methods and compositions concerning allergy in dogs
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US6060326A (en) 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
DE69922873T2 (en) 1998-04-09 2005-12-29 Idexx Laboratories, Inc. Specific binding proteins for the treatment of allergies in dogs
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate

Also Published As

Publication number Publication date
EP1254180A1 (en) 2002-11-06
JP4605973B2 (en) 2011-01-05
WO2001057090A1 (en) 2001-08-09
DE60127237D1 (en) 2007-04-26
JP2003521916A (en) 2003-07-22
EP1254180B1 (en) 2007-03-14
US6504013B1 (en) 2003-01-07
DE60127237T2 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
AU2001233102A1 (en) Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
TWI367102B (en) Therapeutic human anti-il-1r1 monoclonal antibody
AU2002220843A1 (en) Humanised antibodies and uses thereof
HK1078589A1 (en) Anti-human tenascin monoclonal antibody
AU2002251562A1 (en) Anti-CD40 monoclonal antibody
AU2002332290A1 (en) Recombinant anti-osteopontin antibody and use thereof
AU2002338015A1 (en) Human CDR-grafted antibodies and antibody fragments thereof
IL212419A0 (en) Methods of administering anti-tnf antibodies
IL156030A0 (en) Humanized antibodies
AU2001236073A1 (en) Gene recombinant antibody and its fragment
PL366307A1 (en) Humanized anti-lt-beta-r antibodies
NO20034396L (en) Recombinant antibody expressed with GnTIII
EP1499352A4 (en) Recombinant anti-interleukin-9 antibodies
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
EP1178829A4 (en) Human monoclonal antibody
AU2002320790A1 (en) Human type antihuman IgE receptor antibody and antibody fragment
AU2001291050A1 (en) Viral chemokine-tumur antigen fusion proteins
IL158846A0 (en) A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
AU2001281099A1 (en) Production of human monoclonal antibodies
AU6227800A (en) Recombinant antibody directed against human sperm antigen
GB0017139D0 (en) Human monoclonal antibodies
GB0016824D0 (en) Human monoclonal antibodies
AU2001272529A1 (en) Monoclonal antibody against human cathepsin w
GB0020794D0 (en) Humanised antibodies